Journal article
Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study
S McGregor, D Saulo, J Brotherton, B Liu, S Phillips, SR Skinner, M Luey, L Oliver, M Stewart, SN Tabrizi, S Garland, JM Kaldor
Vaccine | ELSEVIER SCI LTD | Published : 2018
Abstract
Background: Cervical cancer occurrence and mortality are strongly correlated with socioeconomic disadvantage, largely due to unequal access to screening and treatment. Universal human papillomavirus (HPV) vaccination provides the opportunity to greatly reduce this global health disparity. Australian Indigenous women have substantially higher rates of cervical cancer than non-Indigenous women, primarily due to under-screening. We investigated HPV infection rates in Indigenous women 7 years after implementation of the national HPV vaccination program. Methods: We used a repeat cross-sectional design, with the baseline being provided by an HPV prevalence survey among Indigenous women attending ..
View full abstractGrants
Funding Acknowledgements
The study was funded by the Australian Government Department of Health. Bette Liu and John Kaldor are funded by NHMRC Fellowships. The funding sources had no role in the preparation of the manuscript or decision to submit for publication.The National HPV Vaccination Program Register is fully funded and owned by the Australian Department of Health and is operated by the Victorian Cytology Service.